PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+59.23%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.54B
AUM Growth
+$1.54B
(+25%)
Cap. Flow
-$70.3M
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
50.34%
Holding
230
New
58
Increased
26
Reduced
57
Closed
33
Top Buys
| 1 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$21.1M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$17M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$16.9M |
| 4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$16.2M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$15.4M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$46.2M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$45.8M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$36.9M |
| 4 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$25.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$22.8M |
Sector Composition
| 1 | Healthcare | 92.13% |
| 2 | Technology | 0.1% |
| 3 | Consumer Discretionary | 0.08% |
| 4 | Industrials | 0.07% |
| 5 | Consumer Staples | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sarepta Therapeutics
SRPT
$1.78B
| $209M | 13.46% | 3,395,236 -372,080 | -10% | -$22.8M |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $125M | 8.09% | 2,476,272 -321,695 | -11% | -$16.3M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $104M | 6.74% | 14,116,644 -1,122,800 | -7% | -$8.31M |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $68.4M | 4.42% | 682,415 -461,200 | -40% | -$46.2M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $54.8M | 3.53% | 2,446,482 -832,898 | -25% | -$18.6M |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $53.8M | 3.47% | 2,334,168 +126,500 | +6% | +$2.92M |
|
|
ARAV
7
DELISTED
Aravive, Inc. Common Stock
ARAV
| $49.4M | 3.19% | 4,028,685 +1,192,931 | +42% | +$14.6M |
|
|
NXTM
8
DELISTED
NxStage Medical Inc.
NXTM
| $41.7M | 2.69% | 1,669,703 +287,293 | +21% | +$7.18M |
|
9
Xencor
XNCR
$580M
| $36.6M | 2.37% | 1,496,229 -33,345 | -2% | -$817K |
|
|
LJPC
10
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $31.5M | 2.03% | 1,323,324 -9,491 | -0.7% | -$226K |
|
11
Iovance Biotherapeutics
IOVA
$807M
| $29.4M | 1.9% | 3,567,553 -44,423 | -1% | -$366K |
|
12
Wave Life Sciences
WVE
$1.53B
| $22.2M | 1.43% | 683,448 +160,853 | +31% | +$5.22M |
|
|
XLRN
13
DELISTED
Acceleron Pharma Inc.
XLRN
| $21.3M | 1.38% | 589,890 -13,146 | -2% | -$476K |
|
|
CLCD
14
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $21.1M | 1.36% | +552,030 | New | +$21.1M |
|
15
Talphera
TLPH
$11.1M
| $21M | 1.36% | 5,408,728 -587,032 | -10% | -$2.28M |
|
|
QTNT
16
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $20.9M | 1.35% | 2,671,794 +422,727 | +19% | +$3.31M |
|
|
DBVT
17
DBV Technologies
DBVT
$264M
| $20.5M | 1.32% | 563,268 +16,572 | +3% | +$602K |
|
18
Corbus Pharmaceuticals
CRBP
$115M
| $18.3M | 1.18% | 2,701,023 -498,977 | -16% | -$3.39M |
|
19
Regenxbio
RGNX
$451M
| $18M | 1.16% | 1,282,286 +183,073 | +17% | +$2.56M |
|
|
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
| $17M | 1.09% | +313,502 | New | +$17M |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $16.9M | 1.09% | +1,363,711 | New | +$16.9M |
|
|
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
| $16.2M | 1.05% | +2,209,657 | New | +$16.2M |
|
23
DexCom
DXCM
$29.5B
| $15.7M | 1.01% | 178,849 +53,675 | +43% | +$4.71M |
|
|
AERI
24
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $15.4M | 0.99% | +406,771 | New | +$15.4M |
|
25
Aldeyra Therapeutics
ALDX
$351M
| $15.2M | 0.98% | 1,940,458 | – | – |
|